Navigation Links
ASM Recommends Nasopharyngeal Flocked Swabs as the Specimen of Choice for Influenza A Testing (Including H1N1)
Date:10/27/2009

MURRIETA, Calif., Oct. 27 /PRNewswire/ -- Preparing for this flu season, the American Society for Microbiology (ASM) PSAB Committee on Laboratory Practices has recently published a new interim algorithm providing guidance to clinical laboratories responsible for testing patients with respiratory illness for Influenza A, including H1N1. The document provides a detailed flowchart that guides microbiologists and physicians through patient assessment and differential diagnosis, and provides recommendations for confirmatory testing. The algorithm focuses particular attention on the critical first step, collection of an optimal specimen, because this step determines the sensitivity and accuracy of the diagnosis. The ASM recommends Nasopharyngeal (NP) Flocked Swabs, patented and manufactured by Copan, as the specimen of choice for Influenza testing. In addition to NP Flocked Swabs, NP aspirates, NP washes, or nasal aspirates are also recommended for testing.

Until the introduction of Copan Flocked Swabs, NP aspirates and washes had been the gold standard for specimen collection for respiratory virus diagnostics because traditional fiber swabs are inferior in terms of the amount of patient sample they collect and the ability to transfer that sample into the test platform. Conversely, the aspirate or wash procedure rinses and removes large quantities of patient sample. The widespread endorsement of Flocked Swabs is attributed to the unique design of the applicator which enables improved sample collection and transfer. The success of Flocked Swabs for Influenza testing is due to a combination of a brush-like action that dislodges large numbers of infected cells and capillary hydraulics, which draws liquid sample between the perpendicular fibers. The Flocked Swabs have a unique mechanical and hydrophilic advantage over any other swab technology. Unlike fiber swabs, which absorb well but entrap the sample in a mattress core, and foam swabs, which are hydrophobic and have poor sample uptake, Flocked Swabs collect a large sample volume -- almost four times more than foam swabs -- and then spontaneously release it into any test system.

Endorsement of Copan Nasopharyngeal Flocked Swabs as the specimen of choice for Influenza testing follows the publication of numerous clinical studies that demonstrate equivalent or better test results when compared with NP aspirates or washes. Copan Flocked Swabs are easier to use, cause less patient discomfort and can be used for sample collection at remote centers, whereas NP aspirates and washes must be performed in a hospital setting by trained personnel with material cost that exceeds that of Flocked Swabs. Copan Flocked Swabs are the best swab technology for Influenza testing that equates to the high specimen yields that laboratory professionals are accustomed to with NP aspirates and washes.

About Copan Diagnostics, Inc.

With a reputation for innovation in preanalytics, Copan is the leading manufacturer of collection and transport systems in the world. Copan offers a complete range of microbial sampling products used for traditional culture analysis and molecular diagnostic assays. For more information, visit www.copanusa.com.

SOURCE Copan Diagnostics, Inc.


'/>"/>
SOURCE Copan Diagnostics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. CDC Advisory Committee Recommends Cervarix To Prevent Cervical Cancer in Girls and Young Women
2. Data Safety Monitoring Board Unanimously Recommends Continuation of Delcaths Phase III Clinical Trial
3. FDA Advisory Panel Recommends Approval of the SEDASYS(R) System
4. HIV/AIDS Research Network Recommends Use of Abbott RealTime Viral Load Test for NIH-Sponsored Clinical Trials
5. FDA Advisory Committee Recommends Approval of Multaq(R) (dronedarone)
6. Task Force Recommends Using Aspirin to Prevent Cardiovascular Disease When the Benefits Outweigh the Harms
7. Independent Data Monitoring Committee Recommends Resuming Enrollment of Non-Squamous NSCLC Patients in the Motesanib MONET1 Trial
8. CHMP Recommends Approval in the European Union (EU) for New Options for Patients With Certain Primary Brain Tumors
9. Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout
10. CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients
11. Task Force Recommends Screening for Hearing Loss in All Newborns
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... April 20, 2017 Research and Markets ... Contract Manufacturing Services Market Analysis By Service (Manufacturing, Research), By ... 2014 - 2025" report to their offering. ... The Latin American pharmaceutical contract ... by 2025 Low drug registration cost in Latin ...
(Date:4/19/2017)... The Mobile X-Ray product segment is the most attractive market ... period Mobile X-Ray segment is the largest segment ... market, which is estimated to be valued at more than ... 7% over the forecast period. Mobile X-Ray segment is expected ... Mn in 2017 over 2016. The segment,s revenue in the ...
(Date:4/19/2017)... , April 19, 2017 Global Prostate ... report on the prostate cancer therapeutics market analyzes ... market. Increasing prevalence of prostate cancer, launch of ... the development of new drugs & therapeutic biological ... drug due to lesser side effects are some ...
Breaking Medicine Technology:
(Date:4/22/2017)... ... April 22, 2017 , ... ... consumers can save an average of 70% when buying medication online from Canadian ... are available when purchasing from other countries. The report (chart below) compares U.S. ...
(Date:4/21/2017)... ... , ... An April 10 article in the Daily Mail describes ... great deal about prehistoric ice-age dental practitioners and their primitive and, no doubt, painful ... decayed dental matter, and that teeth were then filled with bitumen, a substance similar ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... Christopher Salas-Wright finds that youth violence is declining—and at noteworthy rates. Between 2002 ... proportion of young people involved in violence in the United States. The study, ...
(Date:4/21/2017)... ... April 21, 2017 , ... Brady (NYSE:BRC), ... its B-595 and B-7569 vinyl label materials received certification for ... labels are tested to remain intact and legible, for use on chemical drums shipped ...
(Date:4/21/2017)... ... April 21, 2017 , ... The adage “Show, don’t tell” applies perfectly ... in the company’s esteemed VISION House demonstration project series. Manifesting the concept of right-sized ... resources they need to live affordably and abundantly without unduly taxing the resources of ...
Breaking Medicine News(10 mins):